US Stocks
/
MBX Biosciences, Inc. Share Price

MBX Biosciences, Inc. Share Price

NASDAQ: MBX | Mid Cap
$62.90
-$0.96 (-1.5%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MBX Biosciences, Inc. Stock Performance

Open
$62.79
Prev. Close
$63.86
Circuit Range
N/A
Day Range
$62.07 - $63.06
Year Range
$9.82 - $71.83
Volume
28,460
Average Traded
$62.62

MBX Biosciences, Inc. Share Price Today

As of 19 September 2026, MBX Biosciences, Inc.'s share price is $62.90. The stock opened at $62.79, compared to its previous close of $63.86. During today's trading session, MBX Biosciences, Inc.'s share price traded between $62.07 and $63.06, with an average price of $62.56. Over the past 52 weeks, the stock has recorded a high of $71.83 and a low of $9.82. In terms of performance, MBX Biosciences, Inc.'s share price has risen by 110.54% over the last six months and is up 259.33% on a year-on-year basis.

MBX Biosciences, Inc. Share Price Chart

$62.07$63.06
L
Show Current Price
H

MBX Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.30B
PE Ratio (TTM)
-26.43
Dividend Yield
N/A
EPS (TTM)
$-2.38
Revenue (TTM)
N/A
Return On Equity (TTM)
-23.56%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
-19.16%

MBX Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/A
Net Profit-$18.14M-$23.88M-$19.41M-$21.62M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-31.63%18.71%-11.37%

MBX Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
RevenueN/AN/A
Net Profit-$61.92M-$86.97M
Net Profit MarginN/AN/A
Income ChangeN/A-40.45%

About MBX Biosciences, Inc.

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

MBX Biosciences, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$61.95
$62.80
-5.75%
Aug 2026
$65.69
$66.63
+1.02%
Jul 2026
$55.40
$65.96
+19.54%
Jun 2026
$31.57
$55.18
+75.06%
May 2026
$30.48
$31.52
+4.25%
Apr 2026
$31.21
$30.23
+1.21%
Mar 2026
$31.99
$29.88
-8.02%
Feb 2026
$38.31
$32.48
-11.86%
Jan 2026
$31.28
$36.85
+16.71%
Dec 2025
$34.04
$31.57
-8.43%
Nov 2025
$22.01
$34.48
+56.80%
Oct 2025
$17.95
$21.99
+25.62%

MBX Share Price FAQs

What is MBX Biosciences, Inc. share price today?

chevron-up
MBX Biosciences, Inc. share price today is $62.90 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of MBX Biosciences, Inc. stock?

chevron-up
The 52 week high of MBX Biosciences, Inc. stock is $71.83, while the 52 week low is $9.82 as of 19 Sep '26.

What is MBX's market capitalisation today?

chevron-up
MBX market capitalisation is $2.30B as of September 19, 2026, at 6:47 pm IST.

What is MBX's net income for the last quarter?

chevron-up
MBX's net income for the last quarter is -0.02B USD.

What is the 5 year returns of MBX?

chevron-up
The 5 year returns of MBX is 142.11% as on 19 Sep '26.

What is the high & low stock price of MBX today?

chevron-up
MBX stock price hit a high of $63.06 and low of $62.07 as of 19 Sep '26.

Can I buy MBX shares in India?

chevron-up
Yes. You can buy MBX in India by opening an international trading account.